Target intelligence / Profile preview

Circulating toxin or protein in plasma

Molecular classification
Other
01

Overview

"Circulating toxins/proteins in plasma" is not the name of a single molecular target but rather refers broadly to the diverse array of **proteins** and **potentially toxic molecules** present within blood plasma. These include physiological components such as albumin, immunoglobulins, clotting factors, transporters like lipoproteins, acute-phase reactants involved in inflammation, and pathological entities such as misfolded monoclonal immunoglobulins seen in certain cancers or exogenous/endogenous toxins. Plasma proteins play essential roles in transport functions (lipids by lipoproteins), immune defense (immunoglobulins), hemostasis (clotting factors), maintenance of oncotic pressure (albumin), and modulation of inflammation. Some can become pathogenic when abnormally expressed or structurally altered—such as monoclonal light chains causing amyloidosis or myeloma kidney injury—or when they act as mediators/biomarkers for diseases including cardiovascular conditions, autoimmune disorders, cancer, neurodegeneration, among others. Therapeutically relevant interventions may involve replacing deficient beneficial proteins using purified/recombinant products, removing harmful ones through plasmapheresis/exchange transfusion procedures, or targeting them pharmacologically if they drive pathology. Because "circulating toxins/proteins in plasma" is an umbrella term rather than a specific molecule/receptor entity—and encompasses hundreds to thousands of distinct targets—it is **not considered a canonical therapeutic target** itself but rather describes a class/category that includes many individual targets with unique properties. If you require structured information on any *specific* circulating protein/toxin—such as "albumin," "factor VIII," "serum amyloid A," etc.—please specify the exact molecule for detailed data extraction.

Other names
Plasma proteinPlasma toxinCirculating plasma proteinBlood-borne toxinBlood plasma protein
02

Mechanism of action

For therapeutics targeting specific plasma proteins/toxins: Replacement therapy for deficient coagulation factors restores missing factor to enable normal coagulation. For removal of circulating toxins/proteins: Plasmapheresis removes pathogenic substances from circulation.

03

Biological functions

Transport of molecules (for proteins like albumin and lipoproteins)Immune response (for immunoglobulins and acute-phase proteins)Coagulation (for clotting factors)Inflammation modulationOther
04

Disease associations

Cardiovascular disease (e.g., atherosclerosis via lipoproteins)Hematologic disorders (e.g., hemophilia via clotting factor deficiencies)Autoimmune/inflammatory diseasesCancer (as biomarkers or contributors to paraneoplastic syndromes)Neurodegenerative disease
05

Safety considerations

Risk of infection transmission with plasma-derived products.Allergic reactions.Volume overload in susceptible patients.Some circulating toxins can cause direct tissue toxicity if not cleared.
06

Interacting drugs

Albumin human

2 more in the full profile.

07

Biomarkers

Serum amyloid ACalgranulin AC-C motif chemokine ligand 5Hemopexin

Beyond the preview

Go deeper on Circulating toxin or protein in plasma.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Circulating toxin or protein in plasma.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call